These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 22483089)

  • 41. Lipid Lowering Oxopropanylindole Hydrazone Derivatives with Antioxidant and Anti-hyperglycemic Activity.
    Varshney K; Gupta AK; Sonkar R; Varshney S; Mishra A; Bhatia G; Gaikwad A; Srivastava AK; Saxena M; Jain S; Saxena AK
    Curr Top Med Chem; 2018; 18(26):2256-2265. PubMed ID: 30569857
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design, synthesis and biological evaluation of GY3-based derivatives for anti-type 2 diabetes activity.
    Fan L; Wang J; Ma X; Xiao W; Li Z; Zhong G; Tang L; Wu H
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1500-5. PubMed ID: 25724827
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Synthesis and insulinotropic activity of 2-benzylidenesuccinic acid derivatives].
    Gao LM; Yang P; Song DQ
    Yao Xue Xue Bao; 2005 Dec; 40(12):1122-6. PubMed ID: 16496677
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The actoprotective action of thiazoloindole antihypoxic agents].
    Gavreev AI; Marysheva VV; Shabanov PD
    Eksp Klin Farmakol; 2010 Feb; 73(2):25-30. PubMed ID: 20369598
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis of diosgenin-ibuprofen derivatives and their activities against insulin-dependent diabetes mellitus.
    Xin G; Wang Y; Guo X; Huang B; Du D; He S; Zhang R; Xing Z; Zhao H; Chen Q; Huang W; He Y
    Chem Pharm Bull (Tokyo); 2013; 61(5):532-8. PubMed ID: 23649196
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Noble 2-[3-(cyclopentyloxy)-4-methoxyphenyl]-1-isoindolinone derivatives. part I: synthesis and SAR studies for the inhibition of TNF-alpha production.
    Park JS; Baik KU; Cho JY; Yoo ES; Byun YS; Park MH
    Arch Pharm Res; 2001 Oct; 24(5):367-70. PubMed ID: 11693533
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New lead found to a possible "insulin pill".
    Gura T
    Science; 1999 May; 284(5416):886. PubMed ID: 10357667
    [No Abstract]   [Full Text] [Related]  

  • 48. A novel hydroxyfuroic acid compound as an insulin receptor activator. Structure and activity relationship of a prenylindole moiety to insulin receptor activation.
    Tsai HJ; Chou SY
    J Biomed Sci; 2009 Jul; 16(1):68. PubMed ID: 19642985
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quaternary isothiazolylpyridinium salts. Oral hypoglycemic agents.
    Wiegand GE; Bauer VJ; Safir SR; Blickens DA; Riggi SJ
    J Med Chem; 1971 Oct; 14(10):1015-6. PubMed ID: 5115681
    [No Abstract]   [Full Text] [Related]  

  • 50. Computational Tools in the Discovery of FABP4 Ligands: A Statistical and Molecular Modeling Approach.
    Floresta G; Gentile D; Perrini G; Patamia V; Rescifina A
    Mar Drugs; 2019 Oct; 17(11):. PubMed ID: 31683588
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and biological evaluation of substituted 2,2'-oxybis(propionic acid) derivatives and related compounds.
    Bennett GB; Houlihan WJ; Mason RB; Engstrom RG
    J Med Chem; 1976 May; 19(5):709-14. PubMed ID: 1271412
    [No Abstract]   [Full Text] [Related]  

  • 52. Insulinotropic action of (2S)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl) propionate. II. Ionophoretic and conformational aspects.
    Malaisse WJ; Nadi AB; Malaisse-Lagae F; Sato F; Lins L; Brasseur R
    Gen Pharmacol; 1995 Oct; 26(6):1319-25. PubMed ID: 7590126
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Green one-pot three component synthesis of thiazolidine-2,4-dione based bisspirooxindolo-pyrrolidines with [Bmim]BF
    Rukyanaik V; Gamidi RK; Kumari J; Sriram D; Basavoju S
    Mol Divers; 2024 May; ():. PubMed ID: 38789853
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Unveiling the Role of the Fatty Acid Binding Protein 4 in the Metabolic-Associated Fatty Liver Disease.
    Moreno-Vedia J; Girona J; Ibarretxe D; Masana L; Rodríguez-Calvo R
    Biomedicines; 2022 Jan; 10(1):. PubMed ID: 35052876
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intermittent High Glucose Exacerbates A-FABP Activation and Inflammatory Response through TLR4-JNK Signaling in THP-1 Cells.
    Li H; Luo HY; Liu Q; Xiao Y; Tang L; Zhong F; Huang G; Xu JM; Xu AM; Zhou ZG; Dai RP
    J Immunol Res; 2018; 2018():1319272. PubMed ID: 29850615
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis, activity, and docking study of phenylthiazole acids as potential agonists of PPARγ.
    Ma L; Wang T; Shi M; Ye H
    Drug Des Devel Ther; 2016; 10():1807-15. PubMed ID: 27313447
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolic functions of FABPs--mechanisms and therapeutic implications.
    Hotamisligil GS; Bernlohr DA
    Nat Rev Endocrinol; 2015 Oct; 11(10):592-605. PubMed ID: 26260145
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and anti-tuberculosis activity of the marine natural product caulerpin and its analogues.
    Canché Chay CI; Gómez Cansino R; Espitia Pinzón CI; Torres-Ochoa RO; Martínez R
    Mar Drugs; 2014 Mar; 12(4):1757-72. PubMed ID: 24681629
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IL-1β, RAGE and FABP4: targeting the dynamic trio in metabolic inflammation and related pathologies.
    Hardaway AL; Podgorski I
    Future Med Chem; 2013 Jun; 5(10):1089-108. PubMed ID: 23795967
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design, synthesis and biological evaluation of thiazole- and indole-based derivatives for the treatment of type II diabetes.
    Xu Q; Huang L; Liu J; Ma L; Chen T; Chen J; Peng F; Cao D; Yang Z; Qiu N; Qiu J; Wang G; Liang X; Peng A; Xiang M; Wei Y; Chen L
    Eur J Med Chem; 2012 Jun; 52():70-81. PubMed ID: 22483089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.